Integration (CEO Hee-Beom Jeong), a Korean medicine integrated management platform company, announced on the 24th that it has completed raising a total of 27.5 billion won in investment. Altos Ventures led the round, with participation from TBT.
Founded in 2019, Integration operates the Korean Medicine Doctors' Community, "Medistream." Over 85% of registered Korean Medicine Doctors in Korea are members, with approximately 23,700 active members. The company is expanding its business with the goal of innovating Korean Medicine clinic management structures and advancing K-Han Medicine into the global market through specialized Korean Medicine clinic commerce, branding, and EMR/CRM services.
The domestic market for Korean medicine clinics and hospitals is worth approximately KRW 8 trillion, with 96 million patient visits annually. Most are privately operated, burdened by non-clinical work. Integration helps Korean medicine practitioners focus on providing care and increasing sales by streamlining these non-clinical tasks.
Currently, Integration is developing specialized commerce platforms for Korean medicine clinics, brands (Su, Linda Diet, Acurex), and EMR/CRM programs. The brand business, in particular, achieved sales of KRW 45.4 billion in 2024, a 73% increase year-over-year. Integration provides consumers with reliable herbal medicines and products from Korean medicine clinics and plans to expand into the global market in the future.
CEO Jeong Hee-beom stated, "The goal of this round is to create an environment where Korean medicine doctors can provide excellent treatment and to accelerate global expansion through a popular Korean medicine brand." Altos Ventures cited Integration's unrivaled community, distribution competitiveness, brand creation, and CEO Jeong's leadership as reasons for its investment decision.
- See more related articles
You must be logged in to post a comment.